Search

everythinglearnresearchcommunity

for

Search:↓

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Generalized pustular psoriasis patients often need strong medication and careful treatment due to flare-ups and complications.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Apremilast improved symptoms in patients with severe skin conditions.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Zidovudine may cause hair loss in advanced-stage HIV patients.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

IL-17 and certain immune cells are linked to more severe alopecia areata.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.